Private Sector and Healthcare ValueChain

We are currently conducting a market assessment for selected therapies and molecules in order to gain insights on products, regulation, payer landscape, supply chain dynamics and pricing in select countries in Africa that represent a broad spectrum of the continent's pharmaceutical market, each with unique characteristics and challenges. This involves conducting key informant interviews with key stakeholders including regulatory authorities, health care providers, pharmaceutical companies, distribution and supply chain experts, healthcare policy makers and government officials, insurance and health care financing stakeholders, patient advocacy groups and non-governmental organisations working at grassroots to improve access to healthcare and products. The assessment's objective is to provide a comprehensive analysis on market dynamics and opportunities to shape entry strategies.